ABSTRACT: The application of molecular biology in the study of the pathogenesis of herpes simplex virus type I (HSV-1) has led to significant advances in our understanding of mechanisms that regulate virus behavior in sensory neurons and epithelial tissue. Such study has provided insight into the relationship of host and viral factors that regulate latency, reactivation, and recurrent disease. This review attempts to distill decades of information involving human, animal, and cell culture studies of HSV-1 with the goal of correlating molecular events with the clinical and laboratory behavior of the virus during latency, reactivation, and recurrent disease. The purpose of such an attempt is to acquaint the clinician/scientist with the current thinking in the field, and to provide key references upon which current opinions rest.
Introduction
Herpes simplex virus type 1 (HSV-1) is a large (150 kb) DNA virus capable of lytic and latent infection as part of its pathogenesis. During the initial infection, HSV-I multiplies in the epithelium, invades local nerve endings, and travels by retrograde axonal transport (Johnson, 1964; Wildy, 1967) to neuronal cell bodies in regional sensory ganglia (Stevens and Cook, 1971; Hill et al., 1972) . Although some sensory neurons permit productive infection to occur and are destroyed, most sensory neurons survive the infection and retain the virus in a latent state. During latency, infectious virus and viral antigens are not detected, and HSV-1 evades immune surveillance (Baringer and Swoveland, 1973; Stevens, 1975) . A prominent characteristic of HSV-I is its ability to reactivate from latency and cause viral shedding and/or recurrent disease.
From 40% to 50% of adolescents and 60% to 90% of adults worldwide are infected with HSV-I (Blackwelder et al., 1982; Rodu et al., 1992; Siegel et al., 1992; Gil et al., 1998) . Recurrent lesions occur in approximately 20 to 30% of HSV-I -infected persons who are unable to control reactivated virus released from latency (Young et al., 1976; Spruance et al., 1988) . Recurrent (Ghonim et al., 1988; Sugita et al., 1995) , peptic ulcer disease (Lohr et al., 1990) , erythema multiforme (Brice et al., 1989; Darragh et al., 1991) , as well as significant morbidity in persons infected with a virulent strain or who are immunosuppressed (Corey and Spear, 1986; Bubley et al., 1989; Epstein et al., 1990) . Repeated viral infection may also contribute to co-carcinogenic processes (reviewed in Steele and Shillitoe, 1991; Park et al., 1992; Das et al., 1993) . Many diverse stimuli that trigger HSV-1 recurrences have been identified. Nevertheless, translation of this information has failed to establish clinical treatments that target the neuron where reactivation primarily occurs, and current antiviral therapy does not guarantee the inhibition of recurrence (Spruance et al., 1988) . While a complete picture of the regulatory events that lead to HSV-1 reactivation and recurrent disease is still unknown, valuable information on the molecular aspects of gene activity during latency and reactivation is now available. This article reviews the molecular events reported to occur during the sequential stages of HSV-1 infection (lytic infection, latency, reactivation, and recurrence) and focuses on factors thought to be required for latency, reactivation, and recurrent disease. It is important to keep in mind that many topics regarding the pathogenesis of HSV-I remain controversial, and the findings reported are based largely on animal and cell culture studies. Therefore, the clinical and molecular patterns seen in humans may differ. Represents an expanded view of the internal inverted repeats and immediate adjacent sequences. Location of genes and their orientation within this region are designated.
Lytic Infection
A thorough understanding of the data available on HSV-I latency and reactivation is enhanced by a discussion of HSV-1 lytic infection. The specifics of productive infection have been characterized in vitro, and the reader is referred to other works on the subject for greater detail (Roizman and Sears, 1996) . In humans, lytic infection generally occurs in epithelium. Viral entry involves binding of viral glycoproteins B and C to cell membrane receptors, primarily heparan sulfate moieties (Wudunn and Spear, 1989; Sears et al., 1991a) , penetration of the virion by fusion of the viral envelope with the cell plasma membrane, virion protein release, and capsid transport to the nuclear pore, where viral DNA is released into the nucleus (Tognon et al., 1981) . During the early stages of the productive infection, at least two virion proteins induce viral control over host cell function. The first protein, virion host shutoff protein (VHS), enters the cytoplasm and remains there to cause degradation of cellular and viral RNA (Schek and Bachenheimer, 1985; Kwong et al., 1988; Wagner et al., 1995 Roizman, 1974 Roizman, , 1975  Lagunoff and Roizman, 1995 Sandri-Goldin, 1994; Carter and Roizman, 1996; Prod'hon et at., 1996) , whereas ICP47 prevents a host response to infection (York et al., 1994) . The products of (x genes initiate production of the early (() genes, whose role is to increase nucleic acid metabolism. Viral DNA synthesis is detectable 3 hrs post-infection and continues for another 12 hrs (Roizman et al., 1963 (Roizman et al., , 1965 Igarashi et al., 1993) . Replication of viral DNA occurs in "replication compartments" in the cell nucleus (Knipe et al., 1987; de Bruyn Kops and Knipe, 1988) , first by Cairns' mode followed by the rolling circle mechanism (Ben-Porat et al., 1976; Jacob and Roizman, 1977) . Three viral origins of HSV DNA synthesis and one putative host-dependent origin are used to replicate HSV-1 DNA (Fig. 1) . They are "ori,,", located between cx4 and (22, "oriS2", located between (x4 and c47 (Stow, 1982, Stow and McMonagle, 1983) , "oriL", located between UL29 (the major DNA-binding protein, ICP8) and the DNA polymerase (pol) gene (Locker et al., 1982; Weller et al, 1985) , and "oriH , the putative origin located within the BamHI 0 restriction enzyme digestion fragment of the unique long component of the genome (lacob, 1983; Sears and Roizman, 1990) . Seven viral genes mapping to the L component (ORF UL 5, 8, 9, 29, 30, 42 , and 52) (and possibly one or more host cell proteins) are required to initiate origin-dependent replication of HSV-1 DNA (Wu et al., 1988; Olivo and Challberg, 1991; Monahan et al., 1998) .
The optimal expression of late (y) genes requires viral DNA synthesis mediated by the ( proteins (HarrisHamilton and Bachenheimer, 1985; Honess and Roizman, 1974, 1975) . The y genes typically encode structural components of the virion (i.e., the capsid) and viral glycoproteins. Assembled viral capsids bud through the nuclear membrane, are surrounded by tegument proteins, and are enveloped as they pass through the inner lamella of the nuclear membrane. Progeny virus spread from cell to cell via virus-mediated fusion and potentially enter dendritic termini. In the latter case, viral nucleocapsids are transported by microtubular-dependent axonal flow to the neuronal cell body. HSV-1 DNA is released within the neuron at the nuclear pores (Lycke et al., 1984) . The fate of the neuron is dependent on several factors, including the initial viral inoculum (Sawtell, 1997) , the efficiency of virus replication, the synthesis and expression of the anti-apoptosis (ICP4, y34.5) and neurovirulence (,y34.5) genes (Chou and Roizman, 1994; Leopardi and Roizman, 1996) , and the immune response. Defects in glycoproteins B and D can restrict the virus to the primary site of infection and limit neuro-invasiveness (Izumi and Stevens, 1990; Yuhasz and Stevens, 1993) . The spread of virus into non-neuronal cells of the ganglia and the central nervous system in humans is unusual, but can lead to meningitis or encephalitis (Whitley, 1990) . Hematogenous spread is rare (Whitley, 1996) .
HSV-1 Latency
The concept of latency has evolved over the years with input from such notable persons as Goodpasture (1929) , Pedrau (1938) , Burnett and Williams (1939) , Carton and Kilbourne (1952) , Wildy (1967) , and many others. The current operational definition of latency (reviewed in Roizman and Sears, 1987; Stevens, 1989a) is an infection in which the viral genome is present in a non-replicating state in an infected cell from which the virus can intermittently reactivate. Accordingly, viral antigens characteristic of a productive infection are not expressed, the integrity of the host cell is not compromised, and the immune system fails to recognize the infection. Confirmed sites of HSV-1 latency are sensory neurons. Most investigators agree that the trigeminal ganglion is the primary site of HSV-1 latency (Stevens and Cook, 1971; Bastian et al., 1972; Baringer and Swoveland, 1973; Plummer, 1973; Cook et al., 1974; Walz et al., 1974; Warren et al., 1978; McLennan and Darby, 1980; Kennedy et al., 1983; Price, 1986; Stevens, 1989a) . However, additional sites of latency have been reported and include other sensory ganglia such as the nodose ganglion of the vagus nerve (Gesser et al., 1994) , dorsal root ganglia (Hill et at., 1975) as well as sympathetic ganglia (Warren et at., 1978) , and the brain (Sequiera et at., 1979; Baringer and Pisani, 1994) . The persistence of HSV-1 in non-neuronal tissue has support from several studies (Shimeld et al., 1982; Openshaw, 1983; Tullo et al., 1985; Abghari and Stulting, 1988; Sabbaga et al., 1988; Cook et al., 1991; Openshaw et at., 1995) but remains controversial. What is known about the three distinct stages of HSV-1 latency (establishment, maintenance, and reactivation) is discussed in the balance of this review (Fig. 2) .
Establishment of Latency
The establishment of HSV-I latency is preceded by virus replication at the periphery, a protective immune response mainly mediated by T-lymphocytes and macrophages, axonal transport, and entry into the cytoplasm of the neuron. In the mouse, the virus reaches the trigeminal ganglion within 12 hrs post-infection (p.i.) of the eye (Steiner et at., 1990) , and replication occurs within a minority of neurons between 2 and 10 days (Cook and Stevens, 1973; Hill, 1985; Spivack and Fraser, 1987 (Katz et at., 1990; Steiner et al., 1990; Sedarati et at., 1993) . This suggests that genes that function during HSV-1 replication are not needed to establish latency, and down-regulation of the productive infection appears to carry an advantage toward latency, since full virus replication would culminate in the death of the infected cell. What remains unclear is how viral replicative processes are down-regulated within the neuron during the establishment of latency.
HOST FACTORS
Of the several host factors that contribute to the establishment of latency, the neuron is critical. These highly differentiated cells may contribute to the establishment of latency by restricting expression of the viral genes required for productive infection. Restriction of (x genes has been suggested to arise from the absence or altered function of cellular transcription factors needed for viral gene expression (Roizman and Sears, 1987; Steiner et al., 1990) . Sensory neurons (i.e., adult mouse and rat) notably lack, or have in very low levels, the cellular transcription factors-c-jun, c-fos, and Oct-l-important for gene induction (Valyi-Nagy et at., 1991; Hagmann et al., 1995) . In contrast, neurons may express transcription factors that actively repress viral gene experssion. Two potential repressors, Oct-2 (Leah et al., 1991; Lillycrop et al., 1991) and N-Oct3 (Brn2 or POU3F2) (Hagmann et al., 1995) , have been proposed to compete for the multicomplex binding of Oct-1 with VP16 (Gerster and Roeder, 1988; Kemp et al., 1990; Lillycrop et al., 1994) .
Such interaction would restrict viral immediate-early gene expression by inhibiting VP16 function (He et al., 1989) . Current data are less supportive of the role of Oct-2, since several labs have been unable to detect this transcription factor in sensory neurons by sensitive and specific assays (Hagmann et al., 1995; Turner et al., 1996) .
The immune system contributes to the establishment of latency by suppressing acute HSV-1 infection (reviewed in Mikloska and Cunningham, 1998) and limiting the spread of virus at synaptic junctions (Birmanns et al., 1993) . Immunoglobulin (IgG) binding to antigenexpressing HSV-1-infected neurons limits virus replication (Stevens and Cook, 1974) , but is inefficient in cell killing because of antibody bridging with the virion Fc receptor that limits antibody function (Dubin et al., 1991; Nash and Cambouropoulos, 1993) . This prolongs cell survival and allows time for HSV-1 to enter latency. Likewise, CD8+ cytotoxic T-lymphocytes (CTLs) terminate viral gene expression but fail to induce cytolysis (Oakes and Lausch, 1984; Simmons and Tscharke, 1992) , because (i) infected neurons fail to express major histocompatibility complex (MHC) class I determinants needed for effector cell functions (Jennings et al., 1985; Joly et al., 1991; Oldstone, 1991) , and (ii) the virus interferes with CTL-induced apoptosis (Jerome et al., 1998) . CTLs also suppress viral infection by secreting cytokines (alpha/beta interferon) that have important antiviral properties and aid in the clearance of virus from animals (Feduchi and Carrasco, 1991; Joklik, 1997) . Cytokines may also influence the establishment of latency, since they can alter the transcriptional status of the neuron (Seid et al. 1987; Taga and Kishimoto 1992; Cunningham et al., 1997; reviewed in Wagner and Bloom, 1997) . Together, these findings suggest that immune function is important to animal survival and, thus, to the establishment of an effective latent phase. However, an intact immune function is not regarded as an absolute requirement for the establishment of HSV-1 latency (Moriyama et al, 1992; Valyi-Nagyetal., 1992) .
VIRAL FACTORS Down-regulation of at least two viral processes (i.e., a gene expression and DNA replication) is more than likely critical for the establishment of latency. Studies have shown that inhibition of ox gene expression reduces cellular toxicity and favors establishment of latent infection (Roizman and Sears, 1987; Spivack and Fraser, 1987) . Similarly, latent infection appears to be promoted when DNA replication is restricted by inhibiting (x gene expression in vito, elevating cell temperature (39.5°C-40.5°C) (Wigdahl et al., 1982 (Wigdahl et al., , 1983 Harris and Preston, 1991) , and inhibiting viral DNA polymerase by antiviral drugs (i.e., acycloguanosine, aphidicolin 5-2-bromovinyl-2-deoxvuridine IBVDUI, and phosphonoacetic acid) in vitro (Wigdahl et al., 1983; Wilcox and Johnson, 1988) .
Available data suggest that the regulation of these processes likely involves four viral gene products: VP16, ICP4, ICPO, and the latency-associated transcripts (LAT). The role of VP16 is suggested from studies showing that the avirulent HSV-1 that contains a mutation that reduces the viral trans-activation function of VP16 promotes the establishment of HSV-1 latency in vitro (Harris and Preston, 1991) , in immunocompetent mice (ValyiNagy et al., 1991) , and in mice with severe combined immunodeficiency (SCID mice) (Valyi-Nagy et al., 1992) . However, it is unclear how VP16 function might be altered within the neuron during latency. Investigators have postulated that VP16 levels may be reduced in the neuronal soma, because portions of the tegument are left behind when the virus migrates from terminal nerve endings to the neuron (Sears et al., 1991b) , the protein may be rendered nonfunctional by association with VHS (Smibert et al., 1994) , or it may be inhibited in neural cells (Lillycrop et al., 1994) . Certainly, the competitive inhibition of VP16 binding to a gene promoters by Oct-2 (Leah et al., 1991) or N-Oct3 (Hagmann et al., 1995) may be important. However, VP16 is not likely the sole determinant of the establishment of HSV-I latency, since latency can be established in neurons in the presence (Sears et al., 1991b) and absence of the trans-activation function of VP16 (Steiner et al., 1990) .
ICP4 is essential for the lytic growth of the virus, at least, because of its crucial function as a trans-activator of the a genes required for DNA replication (Everett, 1987) . ICPO is required for the efficient expression of ICP4 and shows the synergistic trans-activation ability of HSV a and -y genes when used in combination with ICP4 (DeLuca et al.,, 1985; Gelman and Silverstein, 1985) . Therefore, quantitative levels of ICPO and ICP4 must decrease for acute infection to decline and latency to be established (Wilcox et al., 1997) . Apparently, this can be accomplished by the absence or reduced function of VP16, the expression of LATs, and/or other cellular and viral factors not yet identified. LATs are a highly conserved family of four RNA species derived from sequences within the long, inverted repeat segments of the HSV genome (see Fig. 1 ) (Rock et al., 1987; Spivack and Fraser, 1987; Stevens et al., 1987) . They are produced during lytic infection and during the establishment of latency. There are three major and stable unpolyadenylated LATs (2.0-kb, 1.5-kb, and 1.45-kb LATs) (Wagner et al., 1988a,b; Wechsler et al., 1988) and one labile, polyadenylated 8.3-kb RNA (Farrell et al., 1991) . The stable LATs overlap about 30% of the 3 end of the mRNA that encodes ICPO (Dobson et al., 1989) , an ao regulatory protein that is important for viral replication (Clements and Stow, 1989; Cai et al., 1993) . The 8.3-kb unstable LAT extends to at least the 3 end of the gene that encodes ICP4 (Mitchell et al., 1990 Although the function of LAT has been elusive, and only rarely has it been found to encode a protein (Doerig et at., 1991) , recent studies have shown that LAT confers two properties important to latency. The first is tissue specificity (Sawtell and Thompson, 1992b) . The second is down-regulation of the expression of a genes and the thymidine kinase gene during acute productive infection (Chen etal., 1997; Garberet al., 1997) . Together, these functions enhance the efficiency of the establishment of latency (Sawtell and Thompson, 1992b; Ramakrishnan et al., 1994; Devi-Rao et al., 1994; Maggioncalda et al., 1996; Thompson and Sawtell, 1997) . The ability of LAT to restrict alpha gene function has been reported to arise from a 3.2-kb fragment of the 5' end of the primary LAT transcript (Perng et at., 1996) . However, the jury remains out on this finding and how LAT transcription blocks cx gene expression. Initial theories purported that LAT provided antisense regulation of ICPO and ICP4, yet Ho and Mocarski (1989) have reported that HSV-1 established latency efficiently without LAT expression. More recently, it has been proposed that ORF P represses ICPO expression by inhibiting splicing (Bruni and Roizman, 1996) that could lead to failure of ICP0 to stimulate expression of ICP4.
Maintenance of Latency
The maintenance of HSV-1 latency requires a quiescent state that is competent in providing a reservoir of infectious virus. The characteristics of this state have been partially defined from studies involving animals and certain types of cell culture, as well as clinical and autopsy studies. From these studies, it is suggested that the DNA of latent HSV-1 is maintained in a minority (0. 1% to 3%) of infected human neurons (Stevens et al., 1987; Baichwal and Sugden, 1988; lavier et al., 1988; Stevens, 1989b; Mehta et at., 1995; Sawtell, 1997) . In experimental animals, the percentage of sensory ganglionic neurons that are latently infected has been reported to be higher (4% to 35%) (Maggioncalda et at., 1996; Sawtell, 1997) , based on detection of LAT RNA by in situ hybridization. However, this is probably a gross underestimate of the total number of neurons that contain latent virus, since not all infected neurons express detectable levels of LAT RNA. Within the neuronal nucleus, latent HSV DNA is maintained as circular" episomal forms (Mellerick and Fraser, 1987; Rock et at., 1987) folded into nucleosomes (Deshmane and Fraser, 1989) . The average copy number of HSV genomes per latently infected neuron during clinical latency is reported to range from 1 to 100 (Cabrera, 1980; Rock and Fraser, 1983; Efstathiou et al., 1986; Stevens et al., 1987; Hill et al., 1996) . However, copy numbers have been reported to exceed 1000 per infected neuron in experimental systems (Sawtell, 1997) .
During the maintenance phase of latency, tran- Johnson, 1987, 1988 (Tenser et al., 1994) . However, TK is dispensable for replication in cell culture (Roizman and Sears, 1996) ; thus, its exact role remains to be defined.
Reactivation from Latency HSV-I reactivation can be viewed as the third phase of latency. Fundamentally, it involves a switch from viral quiescence to a replicative state within the neuron that may occur spontaneously or as a result of physical and emotional stress (reviewed in Roizman and Sears, 1996) . In experimental animals and humans, reactivation is associated with axonal injury (Carton and Kilbourne, 1952; Walz et al., 1974; McLennan and Darby, 1980) , traumatization of peripheral tissues (Hill et al., 1978; Valyi-Nagy et al., 1991) , tooth extraction (Openshaw and Bennett, 1982) , orofacial fracture (Kameyama et al., 1989) , iontophoresis with epinephrine, timolol, and dexamethasone (Kwon et al, 1981; Gordon et al., 1986; Harwick et al., 1987; Hill et al., 1987) , administration of prostaglandins, ultraviolet light radiation IUVRI (Wheeler, 1975; Blyth et al., 1976; Perna et al., 1987; Stanberry, 1989; Laycock et al., 1991) , cadmium (Fawl and Roizman, 1993) , transient hyperthermia (Sawtell and Thompson, 1992a; Moriya et a)., 1994) , and immunosuppression with cyclophosphamide and prednisolone (Hurd and Robinson, 1977) . Ex vivo, reactivation of HSV-1 occurs following explantation of latently infected human neurons (Baringer and Swoveland, 1973) and following superinfection of latently infected, explanted cultures with HSV-2 temperature-sensitive mutants (Lewis et al, 1984) . In culture, HSV-1 reactivation results when the latently infected sympathetic and sensory ganglia of mice, monkeys, and humans are subjected to nerve growth factor (NGF) withdrawal, anti-NGF, 6-hydroxydopamine, colchicine, phorbol myristate acetate, cAMP analogs, dexamethasone, and heat stress Johnson, 1988, 1990; Smith et al., 1992; Halford et al., 1996) . Studies have shown that HSV-1 reactivation is an isolated event limited to only a few neurons within sensory ganglia (McLennan and Darby, 1980; Sawtell and Thompson, 1992a; Halford et al., 1996) . Whether the rate of reactivation is correlated with the number of infected neurons remains to be defined (Maggioncalda et al., 1996) . Select cells are believed to respond by inducing one or more positive factors that permit the virus to overcome repression of (x genes by diluting a repressor (a copy number effect) or altering the physical state of viral DNA (Roizman and Sears, 1987; Wagner and Bloom, 1997) . Although it is unknown whether human neurons survive HSV-I reactivation, available evidence in animals suggests that neurons die upon reactivation (McLennan and Darby, 1980, Hill, 1987) . If this were the case in humans, then why is it that persons who suffer from frequent oral HSV-1 recurrences do not report dysesthesia? This could be explained by the fact that only a limited number of neurons die after reactivation, and the plasticity of the sensory system compensates for minute peripheral sensory loss in orofacial tissues.
HOST FACTORS Cellular stress from neuronal injury (e.g., excising a trigeminal ganglion) activates a cascade of biochemical events that can lead to HSV-1 reactivation. Certain cellular transcription factors appear to be key elements in these signal transduction pathways. For example, the expression of c-fos, c-jun, c-myc, Oct-1, and interferon regulatory factor-i (IRF-1) is low in adult sensory neurons (Leah et al., 1991; Valyi-Nagy et al., 1991 , Tal-Singer et al., 1998 . However, their expression is rapidly induced as a result of reactivation events such as axotomy and axonal transport block (Leah et al., 1991; Tal Singer et al., 1997 ). Induction of c-fos by NGF in neuronal cells is blocked by 2-aminopurine 12-API (Volonte et al., 1989) , and 2-AP inhibits HSV-1 reactivation from cultured ganglionic neurons (Smith et al., 1992) . As stated before, Oct-1 binding promotes the trans-inducing function of VP16 on a genes. Thus, viral reactivation may occur when neurons increase expression of Oct-or c-fos following traumatic events (Kemp et al., 1990; Lillycrop et al., 1991) . Alternatively, axotomy and withdrawal of NGF may dilute Oct-2 activity or induce apoptotic factors conducive to HSV-1 reactivation (Stefanis and Burke, 1996) . Although several reactivation stimuli (UVR) are known to induce other transcription factors (API and NF-KB) (Baeuerle and Baltimore, 1988; Stein et al., 1989) , the role of these and other transcription factors in HSV-I reactivation has not been fully explored. Consensus SPI binding sites are located throughout the viral genome and in most viral cx and K promoters (reviewed in Roizman and Sears, 1996) . Likewise, interleukin (IL)-6, an inflammatory cytokine produced in the trigeminal ganglion, can induce transcription factors that appear to regulate the LAT and ICP0 genes (Kriesel et al., 1997) . Perhaps these factors activate viral cx genes or multiple kinetic classes of viral genes required for reactivation.
At least two cellular second-messenger pathways (i.e., cAMP and protein kinase C) appear to be involved in HSV-1 reactivation in vitro (Smith et al., 1992 (Rodbell, 1980; Levitzki, 1988, Hu and Gudas, 1990) , isobutylmethylxanthine IIBMXI, and forskolin (Huang et al., 1982) Adenylate cyclase raises intracellular levels of cAMP that results in the binding of cAMP with protein kinase A (PKA) and the release of catalytic subunits that can phosphorylate specific transcription factors (Montminy and Bilezikjian, 1987; Roesler et al., 1988; Mellon et al., 1989) . These events could have significance to HSV-1 reactivation, because the LAT pro-moter is cAMP-responsive (Leib et al., 1991) and the presence of LATs is correlated with efficient reactivation. In addition, phosphorylation may contribute by activating transcription factors and viral proteins (i.e., ICPO and ICP4) critical for efficient virus replication (Xia et al., 1 
996a,b).
A third cellular element important for review, because it may contribute to HSV-1 reactivation, is the stress response pathway resulting from heat stress (Sawtell and Thompson, 1992a ) and the inhibition of protein synthesis (Preston et al., 1998) . During the heatstress response, it is thought that the cell produces reactive oxygen species that activate heat-shock transcription factors and heat-shock proteins (HSPs) (Kramer et at., 1990; Jaattela and Wissing, 1992; Wu et al., 1994 ). These in turn may interact with DNA-binding domains of HSV-responsive promoters or change the level of phosphorylation leading to activation of cell inducers or inactivation of cell repressors. The heat-inducible forms of HSPs are constitutively expressed at low levels in unstressed sensory neurons (Plumier et al., 1997) , but are up-regulated after exposure to heat at times coincident with increased HSV-I gene activity (reviewed in Hendrick and Hartl, 1993; Parsell and Lindquist, 1993; Craig, 1993 Thompson, 1992a) , ex vivo (Halford et al., 1996) , and postaxotomy, respectively (Tedeschi and Ciavarra, 1997) . HSPs are also induced during various forms of cellular stress that have associations with HSV-1 reactivation, including viral infection (Wigdahl et al., 1983; Kobayashi et al., 1994) and exposure to heavy metal ions (Fawl and Roizman, 1993) , steroid hormones (Ireland and Berger, 1982; Halford et al., 1996) , and DNA-damaging agents (Fornace et al., 1989) . Protein synthesis pathways appear to be important because the inhibition of protein synthesis has recently been shown to stimulate oa gene (i.e., ICPO and ICP27) expression (Preston et al., 1998) .
VIRAL FACTORS
Has the virus evolved a complex strategy that allows for the induction of reactivation by a variety of pathways? What do the data tell us? a genes There is evidence that the primary viral mediator of the switch from latency to productive infection is an cx gene. The (x4 gene is a candidate because its product ICP4 is absolutely required for the expression of HSV-1 a and -y genes that are essential for lytic infection (Preston, 1979; Dixon and Schaffer, 1980; Watson and Clements, 1980; Batterson and Roizman, 1983; DeLuca and Schaffer, 1985; Chen and Silverstein, 1992; Samaniego et al., 1997) . ICP4 transcripts have been detected in latently infected trigeminal ganglia (Kramer and Coen, 1995; Chen et al., 1997) , and some ICP4 mutants of HSV-1 are incapable of reactivation (Leib et al., 1989; Sedarati et al., 1993 (Knezetic and Luse, 1986; Felsenfeld, 1992 (Han and Grunstein, 1988; Deshmane and Fraser, 1989) . LAT transcripts may also act to displace histones and maintain access to the viral promoters of c-4 and xO. Demethylation of the viral genome may also contribute to reactivation. It has been suggested for many years that undermethylation of DNA within the pre-initiation domain of a promoter region is a prerequisite for gene activation (Levine et al., 1992; Doerfler, 1993) . Consistent with this theory are the findings that methylation of the dinucleotide CpG has an inhibitory effect on gene expression. For example, critical regions of HSV-l DNA, specifically, the HSV-l TK coding region and LAT promoter, have CpG dinucleotide islands potentially methylated during latency (Youssoufian et al., 1982; Graessmann et al., 1994; Wagner and Bloom, 1997) . Further, demethylating agents (i.e., 5-azacytidine and DMSO) enhance transcription of TK (Clough et al., 1982) and HSV-I reactivation kinetics from latently infected ganglionic neurons (Harbour et al., 1983; Whitby et al., 1987) . a genes and DNA replication HSV-1 reactivation cannot occur without a gene expression and DNA replication. However, it remains unclear whether expression of a genes follows the temporal pattern seen during lytic infection (i.e., ox, 3, y) or whether DNA replication occurs at the onset of reactivation. It has been recently reported that, during reactivation, the temporal pattern of gene expression differs from that of lytic infection. Using latently infected murine trigeminal ganglia, Fraser's laboratory detected 1 viral gene products (TK, ICP6, VP5) within the first 4 hrs after explantation, whereas a gene transcripts were not detected until 8 to 24 hrs after explantation (Tal-Singer et al., 1997) . This suggests that neuronal factors that cause reactivation may not act specifically on ca genes, and DNA replication may be an important event that precedes cx gene expression. Viral DNA replication involves the formation of an initiation complex at origins of DNA replication and the production of enzymes, such as thymidine kinase (TK). For HSV-I reactivation, these events require activity at one of the three viral-dependent origins of DNA replication or the putative host-dependent origin (oriH) of DNA replication. At present, the data on origins of DNA replication with regard to HSV-1 reactivation are limited and unconfirmed. However, the existing data do support the enhanced functional activity of these origins in cells under circumstances thought to be related to reactivation. For example, oriL replicates more efficiently in NGFdifferentiated PC12 cells than undifferentiated cells in the presence of dexamethasone (Hardwicke and Schaffer, 1997) . The origin (oriH) has also been reported to be hormone (i.e, estrogen)-responsive (Sears and Roizman, 1990) , and HSV-1 has been shown to replicate more efficiently in estrogen-responsive cells when estrogen is added to the culture medium (Miller et al., 1994) .
The importance of TK in replication and reactivation is evident from many studies. The enzyme is important for normal virus replication in experimental infection (Tenser and Dunstan, 1979) , and chemicals that block thymidine kinase or nucleoside transport inhibit viral reactivation from HSV-1-infected and TK-HSV-1 mutant-infected trigeminal ganglion neurons, respectively. Furthermore, TK-HSV-l mutants do not express LAT efficiently in a transplantation model (Tenser et al., 1994) , do not reactivate in the mouse model (Coen et al., 1989) , and reactivate with very low efficiency in the rabbit model (Meignier et al., 1988) . Together, these studies suggest that replicative enzymes and nucleosides essential for HSV-1 DNA replication may not be in sufficient supply or are restricted in neurons that prevent efficient virus replication until neurons are exposed to reactivation stimuli . Viral copy number Viral copy number, both within individual latently infected cells and the total number within the ganglion, appears important to the mechanism of reactivation (Kosz-Vnenchak et al., 1993; Roizman and Sears, 1996) .
The genome copy number of HSV-l in latently infected neurons has recently been correlated with the ability to reactivate in vivo (Sawtell et al., 1998) . High viral copy number is achieved in neuronal cells during latency by a high multiplicity of infection (Sears et al., 1985b ) with suppression of the acute infection at a critical juncture (Birmanns et al., 1993) and efficient transport of virus to the neuronal nucleus. Under conditions of high viral copy number, there are an increase in the number of origins of DNA replication available for reactivation, an increase in the copies of viral genes critical for reactivation, and an increase in the ability of viral gene products to "dilute out" the repressing activity of cellular factors such as Oct-2 and/or N-Oct3.
HSVW 1 Shedding and Recurrence
After the switch from latency to reactivation and a round of replication, HSV-1 is axonally transported to the periphery, where it can enter basal epithelium and replicate, or undergo an abortive infection (Hill et al., 1983) . The replicative outcomes, controlled by host defense and immunologic mechanisms, are asymptomatic viral shedding or clinically apparent disease (Fig. 2) Crit Rev Oral Biol Med 9(4)-.541-562 (1998) 1970; Kameyama et al., 1988; Jolivald et al., 1990; Kriesel et al., 1994; Tateishi et al., 1994) . Clinically apparent recurrent infections occur in 20 to 30% of HSV-1-infected humans (reviewed in Scott et al., 1997) . The small clusters of vesicles or ulcers involving a limited portion of the initially infected dermatome generally appear within two days of entry into the epithelium. However, the time of the appearance of virus (i.e., within 10 to 96 hours) is variable, because the distance to be traveled is variable (e.g., entry into the oral cavity occurs from several latent sites, including the trigeminal, geniculate, and superior cervical ganglia), the rate of travel is variable (i.e., from 2 to 16 mm/hr, depending on the physiological status of the neuron) (Kristensson et al., 1971 , Kristensson, 1978 Openshaw et al., 1978) , the virus may already be in transit or in epithelium at the time of the stimulation, and the host response can be variable. Though recurrent lesions infrequently can be severe and mimic primary herpetic gingivostomatitis (Christie et al., 1998), antiviral agents (i.e., acyclovir, famciclovir, valicyclovir) are capable of preventing some and reducing the severity of many recurrent infections (reviewed in Miller and Redding, 1992 ; reviewed in Stott, 1997; Schacker et al., 1998) by their DNA chain termination ability. Acyclovir may also prevent recurrences by reducing cytokine gene expression in latently infected trigeminal ganglia (Halford et al., 1997) .
HOST FACTORS Several findings support the concept that certain stimuli induce recurrent HSV-I disease through their action targeted at epithelial cells and the inflammatory response. For example, UVR is a potent and predictable stimulus of epithelial erythema (i.e., inflammation) and recurrent disease in humans and guinea pigs (Perna et al., 1987; Stanberry, 1989) and herpetic keratitis in the mouse (Blyth et al., 1976; Harbour et al., 1983; Shimeld et al., 1990) . However, UVR does not induce reactivation of HSV-1 from latently infected murine trigeminal ganglia (Birmanns et al., 1993) or latently infected neurons in vitro (Wilcox et at., 1990) . The reader may see these findings as somewhat conflicting; however, this may be explained by the effect of UV on HSV-l recurrence from indirect action on epithelium through alteration of inflammatory (i.e., cytokine production) and immunological processes (see next two paragraphs). Also, high spontaneous reactivation frequency as well as persistently infected epithelium can allow the virus to be at epitheliat sites at times coincident with the UVR response. UVR has been shown to enhance HSV-1 replication in non-neuronal cells in vitro (Lytle, 1971; Coppey, 1977; Miller and Smith, 1991) and probably has a similar effect in vivo. This could help explain the rapid development of recurrent herpes in some patients within the first 48 hours after ultraviolet light exposure (Rooney et al., 199 1; Spruance, 1993; Kriesel et at., 1994) -an interval too short to account for neuronal reactivation, transport, and rounds of replication in epithelium required to produce a recurrent lesion.
Sequential immunological events at the periphery appear to contribute to the development of recurrent HSV-1 disease. Evidence suggests that during the early phase of the recurrence, a transient deficit in immunological function that is associated with reduced T-, natural killer (NK), or Langerhans cell number or function occurs (Underwood and Weed, 1974; Norval et al., 1987; Glaser and KiecoltGlaser, 1997) . Later during lesion development, there is an increased lymphocytic response that results from antigenic stimulation by the virus replicating in the lesion (Shillitoe et al., 1977) . The importance of a suboptimal cell-mediated response comes from studies of latently infected animals and humans with defects in T-cells that suffer frequent recurrences (O'Reilly et at., 1977; Nash and Cambouropoulos, 1993) , and recurrences that are associated with factors (i.e., UVR, prostaglandins, and mild tape stripping of epithelial sites) that induce alterations in T-cell function (Norval et al., 1987) . For example, UVR induces erythema and the release of inflammatory mediators (i.e., prostaglandins and urocanic acid (Black et al., 1982; Rudlinger and Norval, 1989) . The urocanic acid mediates suppression of the T-helper-type response (Ross et al., 1986 (Ross et al., , 1988 and delayed-type hypersensitivity (Kripke, 1984; Howie et al., 1987; Ullrich, 1995) . UVR also depletes antigen-presenting Langerhans cells (Aberer et al., 1981) , reduces Langerhans cell ability to induce T-lymphocyte proliferation (Cooper et at., 1985) , induces keratinocytes to release immunomodulatory cytokines and extracellular factors (interleukin 1-a-and -1 fibroblast growth factor) (Schorpp et al., 1984) , as well as increases interleukin (IL)-10 production by monocytes (Rivas and Ullrich, 1992) . IL-10 suppresses delayed hypersensitivity (Rivas and Ullrich, 1994) , whereas IL-6 may stimulate transcription factors important for reactivation (Kriesel et at., 1997) .
Recurrent disease also develops in association with hormones that promote HSV-1 replication and chemicals that suppress the immune response. For example, reactivated virus arriving at epithelium during a state of glucocorticoid-induced anti-inflammation and immunosuppression (reviewed in Miller, 1997) can result in enhanced HSV-1 replication and clinical recurrences. Similarly, other agents (i.e., cyclophosphamide, epinephrine, and emotional stress) may contribute to the development of recurrent HSV-1 lesions, primarily by downregulating important immunological mechanisms (Underwood and Weed, 1974) . Cyclophosphamide, an alkylating agent, demonstrates efficient anti-lymphocyte activity, emotional stress can down-regulate CD56+ (natural killer) cells that have a role in viral surveillance and depress the CD3+/CD8+ that are responsible for cytotoxic action during recurrent HSV-1 infection (Koff 550 Grit Rev Oral Biol Med 9(4)541
550
Crit Rev Oral Biol Med 9(4):541-562 (1998) and Dunegan, 1986; Irwin et al., 1992; Bonneau, 1996) , and epinephrine may promote HSV-1 recurrence by its capacity to suppress natural killer cell margination and the entry of natural killer cells into tissue (Benschop et at., 1993 (Benschop et at., , 1996 .
VIRAL FACTORS
The immunosuppressant effects of certain stimuli are additive to the virus' own ability to protect itself from a strong CD8+ cytotoxic T-cell response (Kuzushima et al., 1990) . Reactivated HSV has been observed to reduce NK activity and lymphokine activity owing to a significant increase of suppressor CD4+ lymphocytes at the time of, or immediately before, the onset of lesions (Sheridan et al., 1985; Cauda et al., 1989) . The increase in CD4+ cells is at the expense of the CD8+ T-cells in HSV-1-associated epithelial lesions (Cunningham et al., 1985; Schmid and Rouse, 1992) . The limited CD8+ T-cell response and resistance to lysis by CD8+ cytotoxic T-lymphocytes have been mapped to the (x47 gene function that causes retention of MHC class I molecules in the cytoplasm and reduced peptide presentation on the infected cell surface (Jennings et al., 1985; York et al., 1994; Hill et al., 1995) . The virus is also protected from antibody-dependent cellular cytotoxicity (Bader et al., 1978) by the participation of the Fc receptor, expressed on the surfaces of HSV--infected cells, that ties up antiviral immunoglobulin G by bipolar bridging (Frank and Friedman, 1989; Dubin et at., 1991 (1998) 
